Jacqueline Weisbein, DO
Pain Medicine · Napa, CANPI 1922275411
Payments from drug & device makers
Across 1,402 payments — averaging $615.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$612K
- Si-bone, Inc.$102K
- Medtronic$90K
- Vertos Medical, Inc.$23K
- Vertex$13K
- Boston Scientific$7K
- plus $16K from 30 others
Across 22 payments — averaging $614.52 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Saluda Medical Americas, Inc.$14K
What the payments were for
- Consulting fees$105,74921%
- Speaking & faculty fees$277,52656%
- Travel & lodging$72,05315%
- Food & beverage$38,4958%
- Education$130%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 995 | $611,712 |
| Si-bone, Inc. | 81 | $102,241 |
| Medtronic(2 entities) | 119 | $89,617 |
| Vertos Medical, Inc. | 38 | $22,660 |
| Vertex | 15 | $13,217 |
| Boston Scientific | 14 | $7,236 |
| AbbVie(2 entities) | 52 | $6,392 |
| Saluda Medical Americas, Inc. | 14 | $4,299 |
| Omnia Medical, LLC | 1 | $1,000 |
| Biotronik NRO, Inc. | 6 | $678 |
| SPR Therapeutics, Inc | 8 | $660 |
| GS Solutions, Inc. | 1 | $651 |
| Electronic Waveform Lab, Inc. | 18 | $379 |
| Spinal Simplicity, LLC | 4 | $357 |
| Stimwave Technologies Incorporated | 3 | $231 |
| Painteq LLC | 3 | $184 |
| Radius Health, Inc. | 5 | $182 |
| Vertiflex, Inc. | 3 | $177 |
| Bioventus LLC | 1 | $145 |
| Penumbra, Inc. | 1 | $140 |
| Amgen | 1 | $125 |
| MML US, Inc. | 2 | $110 |
| Nalu Medical, Inc. | 2 | $82 |
| Nevro Corp. | 1 | $70 |
| Averitas Pharma Inc. | 1 | $58 |
| Assertio Therapeutics, Inc. | 2 | $45 |
| Merz Pharmaceuticals, LLC | 2 | $45 |
| Fidia Pharma USA Inc. | 1 | $26 |
| Relievant Medsystems, Inc. | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| Biodelivery Sciences International, Inc. | 1 | $17 |
| Curonix LLC | 1 | $17 |
| Novo Nordisk | 1 | $17 |
| MDD US Operations, LLC | 1 | $15 |
| Collegium Pharmaceutical, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$178,315
- Neuromodulation Dspsbls and Accs$96,416
- IFUSE IMPLANT SYSTEM$25,709
- INTELLIS$24,928
- RESTORE$22,571
- mild Device Kit$22,129
- Neuromodulation-Research Only$17,314
- ADAPTIVESTIM$15,988
- JOURNAVX$12,946
- SYNCHROMED$9,002
- Proclaim Family of SCS IPGs$6,888
- CROSSBOSS$6,000
- Nanostim Leadleas Pacemaker$5,700
- BOTOX$5,593
- Evoke SCS$4,177
- Proclaim IPG$2,720
- ETERNA$1,685
- TARGETSTIM$1,446
- iFuse Implant$750
- Cardiovascular- Research only$724
How this compares
$862,855 in reported general payments places this provider in the 95th percentile of 840 pain medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Emgality PenGalcanezumab-Gnlm | 16 | $10,600 |
| Buprenorphine | 24 | $5,543 |
| Celecoxib | 82 | $1,688 |
| Tizanidine Hcl | 115 | $1,457 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 67 | $1,186 |
| Gabapentin | 47 | $878 |
| Pregabalin | 26 | $429 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 24 | $402 |
| Oxycodone Hcl | 18 | $379 |
| Methylprednisolone | 47 | $304 |
| Ibuprofen | 17 | $246 |
| Tramadol Hcl | 38 | $207 |
| Duloxetine Hcl | 29 | $181 |
| Meloxicam | 28 | $105 |
| Nortriptyline Hcl | 15 | $72 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Napa
- Eric GrigsbyNapa$3.2M
- Jason PopeSanta Rosa$2.8M
- Javid GhandehariSanta Monica$2.7M
- Alexander HerselThousand Oaks$2.1M
- Krishnan ChakravarthyTemecula$1.9M
- Kasra AmirdelfanWalnut Creek$1.7M
- Ramana NaiduLarkspur$1.6M
- Foead GeulaStudio City$1.3M
- Xiang QianRedwood City$941K
- Sean AtaeeSanta Ana$855K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.